The Global RNA-Based Therapeutics and Vaccines Market to Grow at a Whopping 86.6% CAGR Between 2022 and 2028

Published On : May 23, 2022

According to a new study conducted by Persistence Market Research (PMR), the Global RNA-Based Therapeutics and Vaccines Market size is expected to hit US$ 2.48 Billion in terms of market value by 2028. The report also says that the Global RNA-Based Therapeutics and Vaccines Market will witness a staggering CAGR of 86.6% from 2022 to 2028.

RNA-based therapeutics and vaccines became successful in 2010. The years 2020 and 2021 witnessed the development of mRNA vaccinations to combat the Covid-19 pandemic. Because of the discovery of mRNA vaccines, the market for RNA-based therapeutics and vaccines is expected to grow rapidly in the near future. Apart from this, the rising prevalence of chronic diseases such as diabetes, tuberculosis, cancer, and certain other cardiovascular conditions, combined with rapid technological advancements in the healthcare sector, will significantly increase the demand for RNA-Based Therapeutics and Vaccines in the near future.

Because of the rising importance of RNA medications in treating rare diseases, the market for RNA-based therapeutics and vaccines in North America has grown significantly. During the projected period, the United States is likely to maintain its lead over the other countries. Due to increased RNA research activities in collaboration with government organizations, the European market for RNA-based Therapeutics and Vaccines will record significant growth. The Asia Pacific region's high prevalence of infectious diseases is also expected to provide enormous potential for the RNA-based Therapeutics and Vaccines market.

The Impact of COVID-19 on the Global RNA Based Therapeutics and Vaccines Market

The emergence of Covid-19 was a disaster for the global economy, but the Global RNA Based Therapeutics and Vaccines Market grew significantly as a result of tremendous research activity that led to the development of mRNA vaccines to fight the Covid-19 pandemic. The development of mRNA vaccines helped to revive the global economy and immunize people against the deadly virus.

View Report Table of Contents, Figures, and Tables

Want More Insights?

PMR has presented a comprehensive report based on RNA-Based Therapeutics and Vaccines Market as per Product Type (Workstations, Reagents and Consumables, Kits (RNA sample preparation and DNA sample preparation)), Application (Research Applications, Diagnostic Testing, Clinical Testing), End User (Diagnostic Centers, Hospitals, Academic & Research Institutes, Forensic Science Laboratories, CROs (Contract Research Organizations)) based on seven regions.

About Persistence Market Research (PMR)

Persistence Market Research (PMR) makes way for advanced, systematic, and refined constellation of the research methodologies that table precise, objective, and sound data. Both – demand and supply side of data from secondary and primary sources are assimilated to give out an all-inclusive market solution for the client/company concerned. Incoherence has no place at Persistence Market Research. Everything is tracked scientifically with proprietary research to add on. As such, risks get minimized and profits maximized with this bottom-up approach.

Rna Based Therapeutics And Vaccines Market

Global Market Study on RNA-based Therapeutics and Vaccines: Post Covid-era to bolster extensive research pertaining to RNA-based therapeutics and vaccines

Rna Based Therapeutics And Vaccines Market